March 27, 2013 — The Heart Failure 2013 LA meeting will include a showcase of several startup companies offering ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
March 25, 2013 — In addition to improving life quality and diminishing pain, total hip replacement (THR) is associated ...
March 21, 2013 — The American College of Cardiology (ACC) and Heart Rhythm Society (HRS), along with key specialty ...
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
Â
March 19, 2013 — Alere Inc. announced the results of research presented at the American College of Cardiology’s 62nd ...
March 13, 2013 — CircuLite Inc. announced it has received conditional approval from the U.S. Food and Drug ...
Â
February 28, 2013 — Medtronic Inc. announced European CE (Conformité Européenne) mark approval for its Engager ...
February 25, 2013 — New research at Saint Louis University shows physicians do not talk to patients about the ...
January 31, 2013 — Belgian biotechnology company, Cardio3 BioSciences (C3BS), a developer of regenerative and protective ...
January 18, 2013 — CardioMEMS Inc. was honored as the 2012 recipient of the Intel Innovation Award. Founder and CEO Jay ...
January 18, 2013 — CardioKinetix Inc. announced the enrollment of the first patients in PARACHUTE IV, the randomized ...
January 3, 2013 — BioVentrix announced it has received CE mark for its Revivent myocardial anchoring system, which makes ...
The annual Transcatheter Cardiovascular Therapeutics (TCT) meeting brings many cutting-edge technologies to the ...
December 19, 2012 — BioControl Medical has announced that the pilot clinical study of its CardioFit vagus nerve ...
December 17, 2012 — BioControl Medical has announced that the pilot clinical study of its CardioFit vagus nerve ...
December 6, 2012 — The U.S. Food and Drug Administration (FDA) granted premarket approval (PMA) for the HeartWare ...